CoChat

The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance

Open access
Stout, Kristen A., Dunn, Amy R., Hoffman, Carlie, Miller, Gary W. · 2019 · ACS Chemical Neuroscience

The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.

Abstract

The synaptic vesicle glycoprotein 2 (SV2) family is comprised of three paralogues: SV2A, SV2B, and SV2C. In vertebrates, SV2s are 12-transmembrane proteins present on every secretory vesicle, including synaptic vesicles, and are critical to neurotransmission. Structural and functional studies suggest that SV2 proteins may play several roles to promote proper vesicular function. Among these roles are their potential to stabilize the transmitter content of vesicles, to maintain and orient the releasable pool of vesicles, and to regulate vesicular calcium sensitivity to ensure efficient, coordinated release of the transmitter. The SV2 family is highly relevant to human health in a number of ways. First, SV2A plays a role in neuronal excitability and as such is the specific target for the antiepileptic drug levetiracetam. SV2 proteins also act as the target by which potent neurotoxins, particularly botulinum, gain access to neurons and exert their toxicity. Both SV2B and SV2C are increasingly implicated in diseases such as Alzheimer's disease and Parkinson's disease. Interestingly, despite decades of intensive research, their exact function remains elusive. Thus, SV2 proteins are intriguing in their potentially diverse roles within the presynaptic terminal, and several recent developments have enhanced our understanding and appreciation of the protein family. Here, we review the structure and function of SV2 proteins as well as their relevance to disease and therapeutic development.

Overview

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.9b00351

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Damaj M. I., 1997, J. Pharmacol. Exp. Ther., 282, 410
  2. Harrod S. B., 2001, J. Pharmacol. Exp. Ther., 298, 172

Cited by

See all 113

Metadata

Authors
Stout, K. A., Dunn, A. R., Hoffman, C., & Miller, G. W.
Affiliations
  • Northwestern University (US)
  • Jackson Laboratory (US)
  • Emory University (US)
  • Columbia University (US)
Corresponding author
  • Stout, Kristen A.
  • Miller, Gary W.
Venue
ACS Chemical Neuroscience
Published
2019-08-08
Volume
10
Issue
9
Pages
3927-3938
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2967602434
Cited by
112
References
167
Citations by year
2026: 16 · 2025: 21 · 2024: 23 · 2023: 19 · 2022: 13 · 2021: 13 · 2020: 5 · 2019: 1
FWCI
0.93
Type
journal article
Language
en
Open access
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
Funders
U.S. Department of Health and Human Services (ES012870, ES023839, NS089242, AG058396, DA037652)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
Keywords
SV2A, SV2B, SV2C, neurotransmitter release, presynaptic terminals, secretory vesicles, levetiracetam, botulinum toxin, Alzheimer's disease, Parkinson's disease, neuronal excitability, paralogs
MeSH terms
Animals, Humans, Membrane Glycoproteins, Nerve Tissue Proteins, Nervous System Diseases, Synaptic Vesicles, Protein Transport

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.